GKB Ophthalmics Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from GKB Ophthalmics Ltd. on BSE

Load latest

GKB Ophthalmics Ltd.

30 May 2025

72.41

-3.17%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Outcome for Outcome Of The Board Meeting Held …

BSE India

The meeting of the Board of Directors was held on May 30, 2025 which inter-alia approved and took on record the Audited Standalone and Consolidated Financials Results of the Company for the quarter and year ended March 31, 2025. Enclosed please find the Standalone and Consolidated financial results together with the Auditors'' Report. The Board of Directors'' Meeting started at 5:15 P.M. and ended at 6.00 P.M. Kindly take the information on record.

pdf

GKB Ophthalmics Ltd.

14 May 2025

72.41

-3.17%

Board Meeting

GKB Ophthalmics Ltd - 533212 - Board Meeting Intimation for Approval Of Audited Standalone And Consolidated …

BSE India

GKB Ophthalmics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2025 ,inter alia, to consider and approve Audited Standalone and Consolidated Financial Results of the company for the quarter and year ended March 31, 2025. The Notice can be accessed at the Company''s Website at www.gkb.net Further,notice is hereby given with reference to the above meeting of the Board of Directors that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulation, 2015, had been closed from April 01, 2025, will now re-open after the completion of 48 hours from the date of submission of financials results to the Stock Exchange. This communication has been sent to all the Directors and all the designated employees of the Company.

pdf

GKB Ophthalmics Ltd.

21 Apr 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Intimation Of Change In Contact Details Of Registrar And Share …

BSE India

We wish to inform that MUFG Intime India Private Limited (''MUFG'') has intimated the company about the change in email address and website as under: 1. Email address: rnt.helpdesk@in.mpms.mufg.com 2. Website: www.in.mpms.mufg.com Further , the RTA has also informed that all the shareholder queries or service requests in electronic mode are to be raised only through their website at https://web.in.mpms.mufg.com/helpdesk/Service_Request.html. We request you to take the above information on record.

pdf

GKB Ophthalmics Ltd.

10 Apr 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Non Applicability Of Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated November 26, 2018.

BSE India

Pursuant to Circular No. SEBI/HO/DDHS/CIR/P/2018/144, dated November 26, 1018, issued by the Securities Exchange Board of India, we hereby confirm that GKB Ophthalmics Limited is not a "Large Corporate", as defined in the said Circular and hence, the said Circular is not applicable to us. Kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

09 Apr 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Credit Rating

BSE India

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations , 2015 , we hereby inform that CRISIL Rating Limited ("CRISIL Ratings") has reaffirmed the credit ratings for the bank -based facilities of the Company , vide their letter dated April 09, 2025. A copy of the Rating Rationale issued by CRISIL is enclosed. We request you to take the above information on record.

pdf

GKB Ophthalmics Ltd.

08 Apr 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

BSE India

Please find herewith Certificate under Regulation 74(5) of SEBI ( Depositories and Participants) Regulations, 2018 , for the quarter ended March 31, 2025 Kindly acknowledge the receipt of the same.

pdf

GKB Ophthalmics Ltd.

02 Apr 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Disclosure Under Regulations 31 (4) Of SEBI (Substantial Acquisition Of …

BSE India

Please find enclosed herewith the disclosure under Regulation 31 (4) of Securities and exchange Board of India (Substantial Acquisition of Shares and Takeover) Regulation 2011 for the financial year ended on March 31, 2025, received from Mr. Krishna Gopal Gupta (K.G. Gupta), Promoter of the Company on behalf of Promoter and Promoter group of the Company. We request you to please take the above information on record.

pdf

GKB Ophthalmics Ltd.

31 Mar 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Intimation Under Regulation 30 Of SEBI( Listing Obligations And Disclosure …

BSE India

In compliance with Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, this is to inform you that the Board of Directors of the Company by way of resolution passed by circulation today i.e. March 31, 2025, has, inter-alia, considered wand approved the following: 1. The Board members took note of the retirement of Mrs. Shashi Katreddi (DIN: 07139250) as an Independent Director Non- Executive Director of the Company with effect from close of business hours on March 31, 2025, due to the completion of her tenure. 2.Further, the Board of Directors of the Company has approved the re-constitution of the Audit Committee, Nomination and Remuneration Committee and Stakeholders'' Relationship Committee with effect from April 01, 2025. We request you to kindly take the above information on record.

pdf

GKB Ophthalmics Ltd.

31 Mar 2025

72.41

-3.17%

Company Update

GKB Ophthalmics Ltd - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) …

BSE India

Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations 2015), intimation be and is hereby given that Krishna Gopal Gupta & Sons (HUF), has purchased 210 equity shares aggregating of Rs. 17,705.36 /- from 25.02.2025 to 25.02.2025, on market , which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulation ,2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulation ,2015, is enclosed herewith along with the copy of disclosure received from Krishna Gopal Gupta & Sons-HUF . Please acknowledge and take the same on record.

pdf

GKB Ophthalmics Ltd.

29 Mar 2025

72.41

-3.17%

SAST

GKB Ophthalmics Ltd - 533212 - Closure of Trading Window

BSE India

Pursuant to SEBI (Prohibition of Insider Trading) Regulations 2015, as amended from time to time , the "Trading Window" for dealing/trading in the shares of the Company shall remain closed from April 01, 2025, till the completion of 48 hours after the declaration of the financial results of the Company for the quarter and financial year ended March 31, 2025. Accordingly, all the Promoters, Directors and Designated Persons of the Company and their immediate relatives are being intimated to not to enter into any transaction involving trading in shares of the Company, during the period of closure of Trading window. Further, the date of Board Meeting at which the said results will be considered, shall be intimated in due course of time.

pdf

Is GKB Ophthalmics Ltd. worth buying?

12 Votes:

Buy 66.67%

Sell 33.33%